Ani Biotech

ANI Biotech is a Finnish biotechnology company specializing in the development and manufacture of rapid diagnostic tests for point-of-care applications. The company utilizes lateral flow immunoassay technology to produce diagnostic kits for cardiac markers, infectious diseases, and gastrointestinal health. In 2011, ANI Biotech was acquired by Biohit Oyj, a Finnish diagnostics firm, to expand its portfolio into the rapid testing market. The company's products are widely used in hospitals and primary care settings to provide immediate results for conditions such as myocardial infarction and Helicobacter pylori infections. ANI Biotech continues to operate as a key component of Biohit's diagnostic division, maintaining its manufacturing and R&D facilities in Vantaa, Finland.